Eosinophilic esophagitis (EoE) represents a chronic, immune-mediated, esophageal disease that is characterized clinically by symptoms related to esophageal dysfunction and histologically by an eosinophil-predominant inflammation [1] . While EoE was originally considered to be a rare disease, today it affects up to 1 in 2,500 individuals in the United States [2, 3] and in Europe [4] . In adults and adolescents, esophageal dysfunction due to EoE manifests itself as dysphagia for solids [5, 6] , leading to long-lasting food impactions that necessitate endoscopic bolus removal in more than one third of the affected individuals [7] . Surprisingly, dysphagia is often regarded as only a nasty molester and not as an alarming symptom, despite the fact that it almost always points to an underlying organic disease of the esophagus such as cancer, EoE or complicated gastroesophageal reflux disease (GERD). EoE patients typically modify their eating habits by strictly avoiding foods of dry and/or rough consistencies, without seeking medical help. As a result, EoE is diagnosed on average 4-5 years after the onset of the first symptoms [8] .
In this issue of Digestion , von Arnim et al.
[9] present a study aimed at evaluating the predictive value of eight clinical and two laboratory markers in a group of 23 adult EoE patients; 20 patients with GERD served as a control group. The purpose of the study was to alert endoscopists
